Recursion Pharmaceuticals to update on FDA trial design for REC-4881 for FAP in the second half of 2026. Analysts expect potential upside from rare diseases.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

哥德尔智能体框架实现了任务策略和元学习算法的同步演化，使多智能体能够探索更广阔的架构设计空间。该研究证明了哥德尔智能体能够通过自指进行递归自我改进，大幅提升复杂推理任务的性能，为突破现有多智能体设计的性能天花板提供了一种全新的范式。而当AI掌握了自我 ...